Literature DB >> 17569893

Diagnosis of peripheral arterial disease of the lower limb.

Andrew W Bradbury, Donald J Adam.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17569893      PMCID: PMC1892495          DOI: 10.1136/bmj.39244.344664.80

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Management of peripheral arterial disease in primary care.

Authors:  Paul Burns; Stephen Gough; Andrew W Bradbury
Journal:  BMJ       Date:  2003-03-15

2.  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

Authors:  D J Adam; J D Beard; T Cleveland; J Bell; A W Bradbury; J F Forbes; F G R Fowkes; I Gillepsie; C V Ruckley; G Raab; H Storkey
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

3.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes; Kevin Bell; Joseph Caporusso; Isabelle Durand-Zaleski; Kimihiro Komori; Johannes Lammer; Christos Liapis; Salvatore Novo; Mahmood Razavi; Johns Robbs; Nicholaas Schaper; Hiroshi Shigematsu; Marc Sapoval; Christopher White; John White; Denis Clement; Mark Creager; Michael Jaff; Emile Mohler; Robert B Rutherford; Peter Sheehan; Henrik Sillesen; Kenneth Rosenfield
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-11-29       Impact factor: 7.069

Review 4.  CT angiography of peripheral arterial disease.

Authors:  Dominik Fleischmann; Richard L Hallett; Geoffrey D Rubin
Journal:  J Vasc Interv Radiol       Date:  2006-01       Impact factor: 3.464

5.  Management of severe ischaemia of the leg.

Authors:  A W Bradbury
Journal:  Br J Surg       Date:  2006-11       Impact factor: 6.939

6.  The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication.

Authors:  Simon D Hobbs; Andrew W Bradbury
Journal:  J Vasc Surg       Date:  2006-08       Impact factor: 4.268

7.  Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.

Authors:  S Khan; M Flather; R Mister; N Delahunty; G Fowkes; A Bradbury; G Stansby
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-12-29       Impact factor: 7.069

Review 8.  MRI of atherosclerosis: diagnosis and monitoring therapy.

Authors:  Christopher M Kramer; Justin D Anderson
Journal:  Expert Rev Cardiovasc Ther       Date:  2007-01

9.  Vessel wall calcifications at multi-detector row CT angiography in patients with peripheral arterial disease: effect on clinical utility and clinical predictors.

Authors:  Rody Ouwendijk; Marc C J M Kock; Lukas C van Dijk; Marc R H M van Sambeek; Theo Stijnen; M G Myriam Hunink
Journal:  Radiology       Date:  2006-09-11       Impact factor: 11.105

Review 10.  Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review.

Authors:  Ros Collins; Jane Burch; Gillian Cranny; Raquel Aguiar-Ibáñez; Dawn Craig; Kath Wright; Elizabeth Berry; Michael Gough; Jos Kleijnen; Marie Westwood
Journal:  BMJ       Date:  2007-06-04
View more
  3 in total

1.  Gadolinium contrast may be risky in kidney disease.

Authors:  Peter C Thomson; Tara A Collidge; Patrick B Mark; Jamie P Traynor
Journal:  BMJ       Date:  2007-06-30

2.  Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients.

Authors:  Hiroaki Ogata; Chiaki Kumata-Maeta; Kanji Shishido; Masahide Mizobuchi; Masahiro Yamamoto; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 8.237

Review 3.  Critical limb ischemia: current challenges and future prospects.

Authors:  Luigi Uccioli; Marco Meloni; Valentina Izzo; Laura Giurato; Stefano Merolla; Roberto Gandini
Journal:  Vasc Health Risk Manag       Date:  2018-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.